Loading...
XJPX
5187
Market cap55mUSD
Dec 05, Last price  
1,024.00JPY
1D
-0.97%
1Q
2.20%
Jan 2017
7.00%
IPO
108.98%
Name

Create Medic Co Ltd

Chart & Performance

D1W1MN
XJPX:5187 chart
P/E
10.25
P/S
0.66
EPS
99.95
Div Yield, %
2.15%
Shrs. gr., 5y
-1.10%
Rev. gr., 5y
3.74%
Revenues
13.03b
+3.53%
9,058,880,0009,017,696,0009,097,359,0009,325,368,0009,331,915,0009,880,617,0009,939,799,0009,650,702,00010,003,003,00010,393,563,00010,796,964,00010,843,961,00010,830,471,00011,698,682,00012,257,294,00012,585,449,00013,030,322,000
Net income
841m
+445.96%
810,326,000625,496,000667,541,000583,382,000512,271,000533,628,000490,059,000333,143,000516,695,000467,961,000672,536,000725,054,000659,523,000660,409,000482,213,000154,022,000840,901,000
CFO
2.25b
+221.93%
1,279,163,0001,003,964,000672,213,000864,538,000322,661,000951,028,0001,223,346,000715,900,0001,443,976,000524,432,000797,921,000880,331,0001,249,020,0001,248,681,000461,344,000698,839,0002,249,762,000
Dividend
Dec 29, 202520 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Create Medic Co., Ltd. researches, develops, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products. The company also provides other products, such as CLINY tracheostomy tubes, endotracheal tubes, tracheostomy tubes, and microcatheters. In addition, it offers OEM products comprising multi-lumen tubes, ultrathin walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on an OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
IPO date
Jul 19, 2000
Employees
1,117
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT